Here's the live share price of Shilpa Medicare along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Shilpa Medicare | -8.50 | 2.98 | 45.43 | 126.51 | 162.69 | 77.08 | 24.87 |
| Sun Pharmaceutical Industries | -0.22 | -4.71 | -10.44 | 3.06 | 5.72 | 15.46 | 15.90 |
| Divi's Laboratories | -4.16 | -2.09 | 23.52 | 45.68 | 36.92 | 34.91 | 10.96 |
| Torrent Pharmaceuticals | -1.61 | -5.16 | -8.34 | 10.67 | 30.22 | 34.01 | 24.21 |
| Zydus Lifesciences | 1.28 | 2.77 | -2.16 | 20.67 | 15.57 | 24.15 | 16.14 |
| Laurus Labs | 1.06 | 5.10 | 29.98 | 80.95 | 130.84 | 71.80 | 25.65 |
| Cipla | 1.39 | -2.78 | -7.99 | 7.86 | -15.07 | 4.35 | 7.92 |
| Dr. Reddy's Laboratories | 3.98 | 6.72 | -0.23 | 0.71 | -0.45 | 3.77 | 4.71 |
| Aurobindo Pharma | 1.90 | 0.50 | 7.87 | 21.64 | 50.84 | 22.55 | 18.43 |
| Mankind Pharma | -2.16 | 2.53 | -7.85 | 10.56 | -4.05 | 8.93 | 10.51 |
| Lupin | 1.34 | -4.25 | -21.02 | -15.87 | 1.41 | 17.99 | 16.00 |
| Glenmark Pharmaceuticals | 2.48 | -4.64 | -1.33 | 0.19 | 19.62 | 41.61 | 34.24 |
| Alkem Laboratories | -0.86 | 0.80 | -8.32 | -6.82 | -6.77 | 12.92 | 6.11 |
| Biocon | 1.48 | -7.05 | -18.52 | 1.06 | -0.56 | 11.69 | 0.67 |
| Abbott India | 1.74 | -0.26 | -5.63 | 0.41 | -12.44 | 5.09 | 4.02 |
| Gland Pharma | -0.65 | 5.89 | 23.79 | 73.69 | 57.59 | 24.65 | -4.06 |
| Ipca Laboratories | -0.49 | -0.76 | 2.24 | 30.45 | 47.47 | 25.83 | 9.73 |
| Anthem Biosciences | -4.31 | -11.36 | 11.17 | 14.56 | 7.70 | 4.58 | 2.72 |
| GlaxoSmithKline Pharmaceuticals | -0.12 | -10.04 | 1.84 | 5.21 | -7.49 | 18.03 | 11.41 |
| Ajanta Pharma | -3.06 | -4.96 | -3.50 | 15.37 | 38.32 | 23.84 | 17.72 |
Source: Dion Global
Over the last one year, Shilpa Medicare has gained 162.69% compared to peers like Sun Pharmaceutical Industries (5.72%), Divi's Laboratories (36.92%), Torrent Pharmaceuticals (30.22%). From a 5 year perspective, Shilpa Medicare has outperformed peers relative to Sun Pharmaceutical Industries (15.90%) and Divi's Laboratories (10.96%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,021.48 | 995.07 |
| 10 | 1,037.66 | 1,010.76 |
| 20 | 1,018.96 | 1,003.08 |
| 50 | 916.5 | 916.98 |
| 100 | 744.66 | 788.18 |
| 200 | 547.89 | 644.02 |
Source: Dion Global
In the latest quarter, Shilpa Medicare remained same as its previous close in promoter holding, while DII stake increased to 8.26%, FII holding rose to 12.11%, and public shareholding moved down to 39.49% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 18,64,657 | 1.24 | 177.01 | |
| 2,35,800 | 1.44 | 22.38 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 10, 2026, 06:11 AM IST IST | Shilpa Medicare - Europe GMP Approval Of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana. |
| Oct 07, 2026, 06:04 AM IST IST | Shilpa Medicare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 23, 2026, 08:39 PM IST IST | Shilpa Medicare - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2 |
| Sep 22, 2026, 09:16 PM IST IST | Shilpa Medicare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 19, 2026, 12:25 AM IST IST | Shilpa Medicare - USFDA Inspection Of Shilpa Medicare Limited, Unit VII, Analytical Services Division, Hyderabad. |
Source: Dion Global
Shilpa Medicare Ltd. is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 597.03 Cr. and Equity Capital is Rs. 19.56 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Shilpa Medicare is ₹926.50 as on Oct 15, 2026.
The Shilpa Medicare is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Shilpa Medicare is ₹18,387.62 Cr as on Oct 15, 2026.
Today’s highest and lowest price of Shilpa Medicare are ₹968.95 and ₹918.00.
The 52-week high/low is the highest and lowest price at which Shilpa Medicare stock has traded in the past 52-week or nearly a year. The 52-week high of Shilpa Medicare is ₹1,095.65 and 52-week low of Shilpa Medicare is ₹260.00 as on Oct 15, 2026.
The Shilpa Medicare has shown returns of -3.87% over the past day, 1.41% for the past month, 43.22% over 3 months, 158.69% over 1 year, 76.03% across 3 years, and 24.42% over 5 years.
P/E ratio of and PB ratio of Shilpa Medicare are 61.85 and 6.85 on Oct 15, 2026. While the company gives a dividend yield of 0.06 per annum.
Source: Dion Global